A streamlined clinical scoring tool could help doctors quickly identify which pneumonia patients need Legionella testing. The SwissLEGIO score — using just five predictors — outperformed the older six-predictor model in a Swiss study, achieving a near-perfect negative predictive value of 98.9%. It's a practical, low-barrier tool for settings where routine Legionella testing isn't standard.
Diagnosing Legionnaires' disease (LD) among patients with community-acquired pneumonia (CAP) can be tricky — and missing it has real consequences. A new Swiss study tested a simplified clinical scoring tool that could make the process faster and more practical, especially in hospitals where routine Legionella testing isn't the norm.
The SwissLEGIO score uses five predictors: elevated CRP (>180 mg/L), low sodium (<133 mmol/L), no or dry cough, fever above 38°C, and prior beta-lactam therapy. It was developed and validated using data from 392 patients across 20 Swiss hospitals, and it outperformed the older six-predictor score — which often fell short because one key lab value (LDH) wasn't routinely measured at most sites.
Key Takeaways:
Why it matters: Legionnaires' disease is underdiagnosed, and delayed treatment worsens outcomes. The SwissLEGIO score gives clinicians a clear, evidence-based checklist to decide who needs testing — no specialized lab required.
